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The diversity of the functions carried out by these various tissues would suggest that airway parasympathetic preganglionic neurons must be segregated anatomically to reflect the location and physiological role of their ultimate effectors. Early studies that used retrograde neuronal tracers indicated that similar to the upper alimentary tract (2, 5) (with which they share a common embryological origin), the airways have a segmental representation in the organization of the vagal preganglionic neurons (17) . Unfortunately, tracer methodologies cannot be applied easily to elucidate whether different tissue structures within an airway segment have a specific representation centrally. The main difficulty resides not only with localizing the tracer injections accurately in the desired tissue but also with preventing the injected material from diffusing to adjacent areas (11) . As a result, the only viable experimental approach to the question of tissue-specific innervation has been to measure physiological airway responses to exogenous stimulation of specific groups of medullary neurons. Using such a technique, Haselton et al. (13) demonstrated that unlike the nucleus ambiguus, activation of neurons in the dorsal motor nucleus of the vagus with homocysteic acid does not increase total lung resistance in dogs. This observation has led to the speculation (15) that neurons projecting to the airways from the dorsal medulla innervate only airway mucus glands and blood vessels.
In the present study, we tested the hypothesis that transepithelial transport of the subunit B of cholera toxin (CTB) deposited into the tracheal lumen would label a distinctive population of preganglionic parasympathetic neurons and sensory fibers in the rat medulla. This hypothesis was based on the recent demonstration that CTB, a widely used retrograde and anterograde neuronal tracer (10, 22) , undergoes transcytotic transport from the apical to the basolateral membrane of polarized intestinal epithelial cells (21) . We performed three sequential experiments. First, we used radiolabeled CTB to confirm that a transport mechanism similar to that described for the intestine exists in the airway epithelium where CTB is translocated from the airway lumen to the subepithelial space and lamina propria. With such information in hand, we then analyzed the topographic distribution of the medullary neurons and sensory fibers labeled by intraluminal CTB. Finally, we examined the question of whether the neuronal population labeled with intraluminal CTB has innervation targets outside the airway mucosa. This was accomplished by counting the number of neurons double labeled by injections of CTB into the tracheal lumen and FluoroGold into the dorsal wall of the trachea or the lung parenchyma.
METHODS
All experiments were performed in male Sprague-Dawley rats (weight, 350-500 g; age, 10-16 wk; Charles River Laboratories, Wilmington, MA) following protocols approved by the Washington University (St. Louis, MO) Animal Studies Committee. The rats were kept at 23°C with access to standard rat feed and water.
Transepithelial transport of radiolabeled CTB in the airways. We performed two series of experiments with 125 I-CTB to determine whether, as we hypothesized, CTB is transported across the airway epithelium and if so, to define its subsequent distribution in the airway wall. For both series, 125 I-CTB was prepared as described previously (19) with 2 mCi of Na 125 I (New England Nuclear, Boston, MA) and 2 IODO-BEADS (Pierce Chemical, Rockford, IL) in a final volume of 200 l with a concentration of 0.08% and a specific activity of 256 counts ⅐ min Ϫ1 ⅐ fM Ϫ1 . The first series of experiments included six rats and was designed to characterize the uptake of 125 I-CTB by the tracheal epithelium. A tracheostomy was performed near the thoracic inlet under pentobarbital sodium anesthesia (50 mg/kg ip). The distal trachea was cannulated, and positivepressure ventilation was begun. A 10-to 30-l volume of 125 I-CTB suspension was instilled in the proximal tracheal segment. After periods of 3, 5, or 7 h (2 rats/period), the rats were killed with an overdose of pentobarbital sodium. The tracheae were then removed, placed in buffered 4% paraformaldehyde fixative for 24 h, and embedded in paraffin. The paraffin blocks were cut transverse to the tracheal axis into 10-m sections that were deparaffinized and mounted on glass slides. Finally, the slides were coated with photographic emulsion (NTB2, Eastman Kodak, Rochester, NY) and processed for autoradiographic analysis. The time elapsed from the experiment to the performance of the autoradiographs was 7 days.
The second series of experiments included eight rats and was aimed at examining the intrapulmonary distribution of 125 I-CTB injected into the tracheal lumen. The rats were anesthetized with halothane (1-4%), and the trachea was cannulated through the mouth with a 14-gauge intravenous catheter that was advanced to the midtrachea. A 30-l volume of 125 I-CTB suspension was then injected into the tracheal lumen. The catheter was finally removed, allowing the rat to breathe spontaneously while it recovered from anesthesia. The injected rats were kept in a radioactive containment hood for 3 h (2 rats), 24 h (3 rats), 4 days (1 rat), or 7 days (2 rats). At the end of this period, each rat was killed with an overdose of pentobarbital sodium. The thoracic organs were exposed through an extended median sternotomy. The pulmonary vasculature was then perfused through a cannula inserted into the pulmonary artery with 0.1 M sodium phosphate-buffered saline followed by 4% buffered paraformaldehyde. The trachea and lungs, esophagus, and duodenum were removed and stored in 4% paraformaldehyde overnight. Two 0.2-to 0.4-cm-thick coronal sections were cut, one from the apex and the other from the base of each lung, and mounted on glass slides. Coronal 0.1-mm sections of the extrathoracic and intrathoracic trachea and esophagus and intact portions of the duodenum and ileum were mounted similarly. The slides were covered with plastic wrap and covered with photographic film to obtain contact autoradiographs. Samples from the same tissues were embedded in paraffin and processed for microscopic autoradiographic analysis as described above.
Intratracheal instillation of CTB. These experiments sought to characterize the topography of neurons and fibers labeled in the medulla by intraluminal CTB. We devised three different methods for the introduction of CTB into the tracheal lumen. Each method contained specific modifications to minimize neuronal labeling via pathways other than transepithelial transport.
In a first group of rats (n ϭ 6), a 200-l volume of 0.1% CTB suspension (List Biological Laboratories, Campbell, CA) was injected through an endotracheal cannula made from a 6-cm section of PE-190 tubing. The cannula was inserted through the mouth under halothane (0.5-4%) anesthesia. After the CTB injection, the lungs were ventilated with a rodent ventilator (Harvard Apparatus, South Natick, MA) for 5-10 min through the same endotracheal cannula used for the injections. The cannula was removed on initiation of spontaneous breathing after discontinuation of mechanical ventilation.
In a second group (n ϭ 10 rats), the anterior surface of the trachea was exposed through a midline incision under pentobarbital sodium anesthesia. A 33-gauge needle (Hamilton, Reno, NV) was then inserted through one of the intercartilaginous spaces. After a small volume of air was aspirated to ascertain that the needle tip was not in contact with the tracheal wall, a 10-l volume of 0.1% CTB suspension was injected into the tracheal lumen. The objective of this transmural technique was to avoid any potential disruption of the tracheal mucosa by the endotracheal cannula. Although the needle puncture interrupted continuity of the epithelial lining, we judged that this interruption was too small to result in substantial contact of deep tracheal tissues with the injectate.
Finally, in a third group of rats (n ϭ 10), a 50-l volume of 0.1% CTB was instilled directly into the tracheal lumen through a tracheostomy. The tracheostomy made it possible to occlude the larynx for a period of 24 h after the instillation, thereby preventing entry of CTB into the gastrointestinal tract. The rats were anesthetized with pentobarbital sodium. After the neck was shaved, a rhomboidal section of skin was removed to prevent obstruction of the tracheostomy stoma by redundant neck tissue. A midline incision was made through the subjacent muscle and fascia to expose the trachea. The first intercartilaginous space was incised transversely, leaving the dorsal wall of the trachea intact. The adventitia was then sewn at the edges of the tracheal stoma to the subcuticular layer of the skin with interrupted suture on a noncutting needle, carefully avoiding perforation of the tracheal mucosa. The stitches were positioned to create a small ridge of free skin, which, on tightening the suture line, became apposed to the edge of the tracheal stoma, protecting it from contact with tracheal secretions. The larynx was packed with cotton through the stoma before the CTB suspension was deposited inside the tracheal lumen with a small Silastic tube. After a period of 24 h, which we deemed sufficient for the disappearance of CTB from the lumen based on autoradiographic determinations with 125 I-CTB, the suture was cut and the laryngeal packaging was removed. The tracheostomy was sutured, this time placing the stitches through the tracheal cartilage to prevent dehiscence.
Double-labeling experiments. The objective of these experiments was to determine whether the parasympathetic preganglionic neurons labeled by intraluminal CTB have concurrent innervation targets outside the airway mucosa. We used two labeling strategies.
In the first (n ϭ 11 rats), we combined instillation of CTB into the tracheal lumen with injections of FluoroGold (Fluorochrome, Denver, CO) into the adventitial membrane that covers the dorsal wall of the trachea. Both the longitudinal trunk and superficial muscular neuronal plexi, which comprise the majority of the intrinsic neurons of the trachea, are embedded in this membrane (3, 9, 33) . The bodies and, presumably, the short dendrites of the neurons from these plexi, however, are separated from the tracheal mucosa by several tissue barriers including the trachealis muscle. The injections were performed under a dissecting microscope while the rats were anesthetized with halothane piped into the inspiratory limb of the ventilator. CTB (100 l of a 0.1% suspension) was injected through an endotracheal cannula as described in Intratracheal instillation of CTB. FluoroGold (0.5 l of a 4% solution) was injected with a glass micropipette mounted on a micromanipulator (Stoelting, Wood Dale, IL). For this purpose, we first lifted the tracheal adventitia immediately anterior to the tracheoesophageal angle with the tip of the pipette. We then advanced the pipette for a short distance in an oblique dorsal direction that kept the tip of the pipette oriented away from the tracheal lumen. The injectate was divided into two to five injections distributed over the length of the extrathoracic trachea. After each injection, the site was blotted with a cotton-tipped probe; at the completion of the injections, the bed of the incision was rinsed with warm saline before the muscle and skin layers were closed with continuous sutures.
In the second strategy (n ϭ 6 rats), we combined intratracheal injections of CTB with injections of FluoroGold into the lung parenchyma. In previous studies (12, 17, 27, 28), we and others have shown that retrograde neuronal markers injected into the lung tissue label numerous vagal motoneurons in the nucleus ambiguus and dorsal motor nucleus of the vagus. This finding is surprising because the lung periphery of mature mammals is considered to be devoid of parasympathetic ganglia (31) and therefore offers no apparent innervation targets for preganglionic neurons. The experiment described here sought to establish whether the same neurons can be labeled by parenchymal injections of FluoroGold and by intraluminal CTB (which we also found confined to an area lacking intrinsic neurons). CTB (100 l of a 0.1% suspension) was injected through an endotracheal cannula as described in Intratracheal instillation of CTB. FluoroGold (2 l of a 4% solution) was injected with a micropipette into the apical lobe of the right lung, which was exposed through a thoracotomy of the fourth intercostal space performed with the animal under halothane anesthesia. Five to ten injections were performed to a 1-to 2-mm depth below the visceral pleura, and lung volume was maintained constant to avoid tearing the lung tissue. After each injection, the pleural surface was blotted with a cotton-tipped probe; at the completion of all injections, the lung surface was washed thoroughly with warm normal saline and allowed to dry for 3-5 min before the thoracotomy was closed by layers. A small Silastic tube was left in the pleural space to evacuate residual air until the rat resumed spontaneous breathing. To rule out the possibility that FluoroGold entering the lung air spaces during the injections could undergo subsequent absorption, we examined the brain stems of six additional rats injected with 10 l of 15% FluoroGold solution into the tracheal lumen. These injections were carried out through an endotracheal cannula with the rats under halothane anesthesia in a fashion similar to that described for CTB.
Identification of labeled neurons and sensory fibers in the brain. On recovery from anesthesia, the rats were returned to the holding facility where they remained for a period of 11-13 days. At the end of this period, each rat was anesthetized with pentobarbital sodium. The heart and large vessels were exposed, and heparin (1,000 U/kg) was injected directly into the right ventricle. A cannula was then inserted into the aortic root, and the systemic circulation was perfused with 0.1 M sodium phosphate-buffered saline followed by 4% buffered paraformaldehyde (pH 7.40), allowing the effluent to exit through a nick in the right atrium. Finally, the brain and spinal cord were removed, placed in 4% paraformaldehyde for 2 days, and stored in buffered 30% sucrose until sectioned. The brain stem and cervical spinal cord were cut into transverse 50-m sections on a freezing microtome. A 1-in-5 series of these sections (amounting to 16 sections/rat medulla) was placed for 30 min at room temperature in a blocking solution of 5% donkey serum (Sigma) in 0.3% Triton X-100 buffered with 0.02 M potassium phosphate. The section series was then incubated overnight at room temperature with primary antisera against CTB (1:10,000 dilution, goat-raised; List Biological Laboratories), FluoroGold (1:500 dilution, rabbit-raised; Chemicon International, Temecula, CA), or both (double-labeling studies). A few representative medullary sections were incubated with CTB antiserum and a guinea pig-raised antiserum that recognizes residues 24-130 of the rat, ␤-preprotachykinin [1:500; courtesy of J. E. Krause Neurogen, Branford, CT (23)] to identify CTB-labeled sensory fibers that contained tachykinins (C fibers). After they were rinsed with buffered saline solution, the sections were placed for 3-4 h in either a 1:100 dilution of biotinylated anti-IgG antiserum (single-labeling studies) or 1:50 dilutions of fluorescent-labeled [FITC and tetramethylrhodamine isothiocyanate (TRITC)] anti-IgG antisera (doublelabeling studies) at room temperature (all raised in donkey; Jackson ImmunoResearch Laboratories, West Grove, PA). After thorough washing with buffered saline, the sections exposed to biotinylated antisera were incubated for 1 h with an avidin-horseradish peroxidase conjugate (VECTASTAIN ABC kit, Vector Laboratories, Burlingame, CA) and stained with 0.05% diaminobenzidine tetrahydrochloride in potassium phosphate-buffered saline containing 0.003% hydrogen peroxide. Staining was intensified by sequential treatment with silver nitrate for 1 h at 56°C, 0.2% gold chloride for 15 min at room temperature, and 5% sodium thiosulfate for 5 min, also at room temperature. The tissue was then counterstained with 0.6% thionin in 0.2 M acetic acid buffer. The sections exposed to fluorescent antisera were simply washed with buffered saline. All the processed sections were mounted on gelatinized glass slides, covered with a buffered glycerol solution (with 0.1% p-phenylenediamine if appropriate to reduce fading during fluorescent viewing), and protected with glass coverslips.
Localization of intrinsic neurons in the rat trachea. The topographic distribution of the intrinsic neurons of the trachea has been analyzed qualitatively and quantitatively in a variety of species including rats (3, 4, 6, 7, 9, 33) . The descriptions resulting from these analyses, however, have varied widely depending on the methodology used to identify the neurons and whether the investigators concentrated their attention only on cholinergic parasympathetic ganglia associated with the nerve trunks. Accordingly, to facilitate the interpretation of our findings, we obtained transverse paraffin-embedded sections of the trachea and esophagus and the lungs of six rats of age and weight analogous to those of the rats used in the preceding experiments. After deparaffinization, the sections were incubated with a rabbit-raised antiserum against rat neurofilament M (Chemicon International) followed by a FITC-labeled donkey anti-rabbit IgG antibody to stain neurons and nerve fibers.
Data analysis. Brain and cervical spinal cord sections treated with biotinylated and fluorescence-labeled secondary antisera were examined with bright-field and fluorescence microscopy, respectively. Labeled neuronal somata and nerve fibers were annotated on a computerized chart of the rat brain (25) , which, after some modification, was also used to illustrate the position of the neurons in Figs. 4, 7, 9, and 10. For analysis purposes, labeled neurons were counted in medullary sections corresponding to ϳ0.5-mm intervals, starting 15 mm below the bregma. Some of the figures, however, contain images selected from intermediate sections for their clarity. The total neuronal counts in the nucleus ambiguus and dorsal motor nucleus of the vagus were analyzed for differences between methods of CTB injection with a Kruskal-Wallis single-factor analysis of variance by ranks. Numerical variables are presented as means Ϯ SD or as medians and 10th and 90th percentiles, depending on whether the individual values followed a normal distribution. All the microphotographs shown in the illustrations were scanned digitally into Adobe Photoshop (Adobe Systems, San Jose, CA) for display and labeling. Whole image color and contrast were adjusted during the scanning process to reproduce the conditions viewed under the microscope.
RESULTS
Transepithelial transport of radiolabeled CTB in the trachea. The first series of experiments that used radiolabeled CTB examined the distribution of 125 I-CTB in the wall of a tracheal segment bound proximally by the larynx and distally by a tracheostomy immediately proximal to the thoracic inlet. Autoradiographic anal- Fig. 1 . Autoradiographic demonstration of transepithelial transport of cholera toxin B (CTB) in rat tracheae. A: bright-field examination demonstrates accumulation of exposed photographic granules, denoting the presence of radioactive tracer in the epithelium and subepithelial space 3 h after instillation of 125 I-CTB into the tracheal lumen. B and C: dark-field (top) and bright-field (bottom) images obtained 3 (B) and 7 (C) h after instillation of 125 I-CTB into the tracheal lumen show that CTB remained confined to the subepithelial space and lamina propria. There was no radioactive signal in deeper layers of the tracheal wall or in the lumen. In the lamina propria, the tracer was concentrated in cells with morphological characteristics of macrophages (inset). C, tracheal cartilage; TM, trachealis muscle. D: dark-field (left) and bright-field (right) autoradiographs illustrate the presence of radiolabeled CTB in the lumen (EL) but not in the walls of the midthoracic esophagus 7 h after instillation of 125 I-CTB into the tracheal lumen. Arrowheads, luminal surface of the esophageal mucosa. Bars, 25 m. http://ajplung.physiology.org/ ysis of tracheal sections confirmed that CTB is indeed transported across the tracheal epithelium (Fig. 1) . The radioactive tracer was detected both in the epithelial cells lining the tracheal lumen and in the subepithelial space and lamina propria at all the time points selected for tracheal fixation (3-7 h after the instillation). In the lamina propria, the tracer was concentrated in cells with the morphological characteristics of macrophages. Unless bound to these cells, radioactivity was absent from the tracheal lumen, even in the rats killed 3 h after instillation of CTB. We found no radioactive tracer in the deeper layers of the submucosa, trachealis muscle, or tracheal adventitia. Small amounts of radioactivity were present in the lumen of the esophagus, especially in its cervical section, where it probably accumulated as a result of diminished swallowing activity during the prolonged anesthesia.
125 I-CTB was not incorporated into the esophageal mucosa.
Distribution of radiolabeled CTB in the airways and lungs. The second series of experiments studied the localization of radioactivity in the lungs after injection of a bolus of 125 I-CTB suspension into the trachea. In this instance, the radiolabeled protein was allowed to progress distally into the airways not only to obtain information about its dispersion in the lungs but also to determine whether the transepithelial absorption observed in the trachea occurred in smaller airways. Contact autoradiographs obtained at various times (3 h to 7 days) after the injection demonstrated accumulations of the radiolabeled tracer in the tracheal and bronchial epithelia and in the lumen of both conducting airways and distal air spaces. Radioactivity was distributed in a patchy pattern throughout the lung parenchyma (Fig. 2) , each patch corresponding to the area subtended by an individual bronchus. At the times studied, the esophagus, duodenum, and ileum had no detectable radioactive residue.
Microscopic analysis demonstrated the concentration of 125 I-CTB in the epithelium and subepithelial space of the intrapulmonary airways from main stem bronchi to small bronchioles (Fig. 3) . Radioactive tracer was present in these locations at all the time points included in the experiment, from 3 h to 7 days after the injections. The signal intensity, however, decreased noticeably with time. We found no signs of radiolabeled CTB in the bronchial adventitia or in the peribronchial or perivascular tissue. Unlike the epithelium of the conducting airways, the epithelial cells lining the peripheral air spaces had no obvious uptake of radioactivity. The radiolabeled protein appeared to form deposits on the alveolar surfaces of the epithelium. Although we cannot exclude that CTB was transported into the interstitial space of the acinus, the persistence of CTB alveolar deposits 7 days after the injections contrasted sharply with the absence of radioactivity in the airway lumina, suggesting that the radiolabeled marker was not absorbed by alveolar cells and thus could not be removed from the air spaces by blood or lymphatic vessels.
Neuronal soma and sensory fiber labeling by intratracheal CTB. Injection of CTB into the tracheal lumen produced extensive labeling of both neuronal somata and sensory fibers in the medulla. Labeled neurons I-CTB into the tracheal lumen. d, Day. For each rat, the tissue samples include a 1-cm longitudinal segment of the midthoracic esophagus (e), coronal sections from the cervical (top) and thoracic (bottom) portions of the trachea (arrows) and esophagus, coronal sections of the 2 lung apexes (top) and bases (bottom), and longitudinal sections of the duodenum and terminal ileum. Radioactive signal was detected only in the trachea and lungs in this 3-h exposure. The signal was strongest in the lungs where it adopted a patchy pattern caused by accumulation of the tracer in distal air spaces subtended by a bronchus (see Fig. 3 ). Some of the lung sections contained no radioactivity, probably as a result of the nonhomogeneous distribution of the 125 I-CTB in the lungs. Even after longer exposures, we found no signs of radioactive tracer in the small intestine. The intense radioactive signal seen in the section of the cervical trachea at 4 days of survival corresponds to a small ring of thyroid tissue. No signal was detected in other sections of the trachea in this rat at the same exposure. were found in all 6 rats injected through the endotracheal cannula, in 5 of 10 rats injected through the tracheal wall, and in all 6 rats that survived after being injected through a tracheostomy.
Neuronal somata were labeled bilaterally in the areas of both the nucleus ambiguus and dorsal motor nucleus of the vagus. The neurons labeled in the nucleus ambiguus were typically multipolar and were Fig. 3 . Autoradiographic microscopic images of the lung parenchyma and intrapulmonary bronchi after injection of 125 I-CTB into the tracheal lumen. A and B: dark-field demonstration of patches of radioactivity in the distal air spaces 3 h (A) and 7 days (B) after the injections. The patches correspond to the areas subtended by subsegmental bronchi. Some of these can be identified by the presence of radioactive signal in the bronchial epithelium. C and D: dark-field microphotographs revealing accumulation of radioactive tracer in epithelial cells and in the subepithelial spaces of both large (3 h postinjection; C) and small (1 day postinjection; D) bronchi. E: bright-field image of the wall of a lobar bronchus 3 h after the injection showing that CTB was confined to the epithelium. F: bright-field image of the distal air spaces 1 day after the injection, demonstrating that the radiolabeled protein remained attached to the alveolar surface of the epithelium but did not appear to undergo substantial transport into the interstitial space. Bars, 50 m.
either concentrated in the compact formation or distributed more loosely in the external formation, sometimes straying in close proximity to the anterior medullary surface (Fig. 4) . Overall, CTB-labeled neurons formed a 3-to 4-mm column in the ventral medulla, extending from the area often referred to as the nucleus retroambigualis to the caudal end of the facial nucleus. The density of the column increased notably between 13 and 11.5 mm below the bregma (Fig. 5) . The neurons labeled in the dorsal nucleus of the vagus were more sparse (Fig. 6 ) and more homogeneously distributed along the caudal-cranial axis than those labeled in the nucleus ambiguus. The method used to inject CTB into the tracheal lumen had no effect on the distribution (Fig. 5) or number (Table 1 ) of labeled neurons, even though the doses of CTB varied substantially with each method.
Sensory fibers were also labeled bilaterally by CTB. Labeled fibers and fiber terminals formed distinctive fields in the area of the nucleus of the tractus solitarius (Fig. 6) , converging in the commissural subnucleus caudally and in the medial and ventrolateral subnuclei more rostrally. Labeled sensory fibers became rare rostral to 13 mm below the bregma. Only a small proportion of the fibers labeled by CTB were immuno- reactive for ␤-preprotachykinin (Fig. 7) , possibly denoting that CTB has a greater affinity for thick than for thin fibers as proposed for its horseradish peroxidase conjugate (30) .
Double-labeling experiments. Labeling of neuronal somata by CTB injected intraluminally and FluoroGold injected into the tracheal adventitia coexisted in all of the 11 rats that underwent the double injections.
The topographic distribution of the neurons labeled by the two markers was similar (Fig. 8) . The number of neurons labeled by FluoroGold, however, was considerably larger (Table 2) , especially in the area of the dorsal motor nucleus of the vagus where labeled neuronal somata usually exceeded 50. Double labeling, indicating uptake of the two markers by the same neuron, was present at all levels of the medulla (Fig. 9) . Approximately half the neurons labeled by CTB in the nucleus ambiguus were also labeled by FluoroGold (median proportion in all rats ϭ 50%, 10th percentile ϭ 15%, 90th percentile ϭ 73%).
Neuronal soma labeling by both markers also coexisted in all six rats injected with CTB into the tracheal lumen and FluoroGold into the right apical lobe. In this case, however, double labeling was present in the majority of the CTB-labeled neurons (90 Ϯ 18% for nucleus ambiguus neurons), indicating a surprising identity between the two neuronal populations (Figs. 8 and 10 ).
FluoroGold produced no detectable labeling of sensory fibers. We also found no neuronal somata labeled by FluoroGold in any of the six rats injected with this marker in the tracheal lumen.
Localization of parasympathetic ganglia in the rat trachea. In the trachea, the majority of the neurofilament M-immunoreactive cells were located in the dorsal adventitia either in association with the longitudinal nerve trunks that run between the trachea and the esophagus or immediately superficial to the trachealis muscle (Fig. 11) . A smaller number of neuronal somata were found in the submucosa, also in the vicinity of the trachealis muscle and, more rarely, in the lamina propria, coming in close proximity to the tracheal epithelium. In the lung tissue, neuronal somata were present only in the adventitial surfaces of large bronchi and pulmonary vessels (Fig. 11) .
DISCUSSION
Our results demonstrate that CTB is transported from the luminal to the basal surface of airway epithelial cells where it is taken up by a substantial number of vagal sensory and motor fibers. Immunohistochemical identification of the labeled motoneurons revealed the existence of an unexpectedly dense innervation of the tracheal and bronchial subepithelial space by medullary vagal motoneurons. (Our observations suggest that it is less likely that CTB was absorbed by alveolar Values are medians; nos. in parentheses, 10th-90th percentiles. Cholera toxin B (CTB) was injected into the tracheal lumen. Tracheostomy was performed after occlusion of the larynx to prevent CTB from entering the gastrointestinal tract. Fig. 6 . Distribution of sensory fibers labeled by intraluminal CTB in the area of the left nucleus of the tractus solitarius of a rat. CTB labeling is demonstrated with diaminobenzidine tetrachloride staining. Left, boxed areas on right at higher magnification. Densest fiber labeling was in the commissural subnucleus (com) in the caudal medulla and in the medial (med) and ventrolateral (vl) subnuclei rostral to the obex. The 3 caudalmost sections also show isolated neuronal somata labeled in the DMV. Cu, cuneate nucleus; Gr, nucleus gracilis; XII, hypoglossal nucleus.
cells, but we cannot exclude that some labeled neurons projected to interstitial targets). Contrary to our stated hypothesis, however, these motoneurons lack a distinctive topographic distribution compared with motoneurons labeled by direct injection of retrograde tracers into the tracheal wall or the lung parenchyma (12, 14, 15, 17, 27, 28) . Moreover, many of the neurons labeled by CTB via the transepithelial route appear to have concurrent innervation targets in the tracheal adventitia and in the lung tissue. These findings contradict the idea that vagal motoneurons are segregated anatomically by the functions of their effector tissues in the airways. They also raise the possibility that some medullary neurons innervate airway targets without interposition of intrinsic neurons.
Transepithelial transport of CTB and labeling of medullary neurons. The pathway of absorption and subsequent disposition of CTB in the trachea recapitulates much of what is known about the transport of cholera toxin in the intestine. When placed in contact with the luminal pole of intestinal cells, the two subunits of the toxin, A and B (CTB), undergo vesicular transport initiated by the binding of CTB to a ganglioside GM1 receptor on the cell surface (20, 21) . The process, which interestingly is three times more efficient for CTB alone than for the two subunits combined (21) , directs the toxin to the basolateral surface of the cell where subunit A exerts its catalytic action. In the intestinal wall, CTB binds to macrophage-like cells analogous to the ones that we observed in the trachea, a property that may facilitate the strong immunogenicity of the toxin (29) .
The idea that once it is transported across the epithelium, CTB remains confined to the subepithelial space and lamina propria is crucial to our interpretation of the neuron-and fiber-labeling patterns reported here. This idea is substantiated by the absence of radioactivity in the tracheal and bronchial submucosa, muscle, and adventitia after intraluminal injections of 125 I-CTB. Even when present in the tracheal lamina propria, the radioactive tracer was associated with macrophage-like cells, which may have carried it there from the subepithelial space.
Selectivity of retrograde and anterograde neuron labeling. In the classic conception of the airway parasympathetic system, vagal motoneurons innervate tissue effectors only through synapses with airway parasympathetic ganglia (1). However, ganglia are rarely found in the lamina propria and are absent altogether from the bronchial subepithelial space and the alveolar interstitium (3, 9, 33) . How then could a retrograde marker such as CTB, which is not transferred transsynaptically or taken up by intact fibers of passage (22) , have labeled such a large number of medullary neurons from these locations?
To answer this question, we must first consider the possibility that medullary vagal motoneurons were labeled by CTB at sites other than the subepithelial space or lamina propria (nonselective labeling) of the airway. CTB was injected into the airways at doses greater than those used by other investigators in direct tissue injections. These large doses, however, do not appear to have resulted in nonspecific labeling of neurons as shown best by the absence of labeled neurons on the side of the medulla ipsilateral to the cervical vagotomies. Deep injury to the tracheal or laryngeal mucosa during endotracheal cannulation may have placed luminal CTB in potential contact with preganglionic fibers innervating the deeper neuronal plexi. We believe that such an event is unlikely, however, because the intensity of neuron and sensory fiber labeling was unchanged when CTB was injected through the tracheal wall with a needle or was placed directly into the tracheal lumen through a tracheostomy. Furthermore, when we injected FluoroGold intraluminally after cannulating the trachea with a similar technique, we found no labeled neurons in the medulla. Swallowing of CTB transported to the pharynx by the retrograde clearance mechanisms of the trachea may have also placed the neuronal marker within the reach of gastrointestinal parasympathetic neurons. Radiolabeled CTB was certainly not transported into the walls of the pharynx or esophagus, which are the only segments of the upper alimentary tract in which motor innervation originates primarily from the nucleus ambiguus (5) . Although gastrointestinal absorption of CTB could account for labeling of some neurons in the dorsal motor nucleus of the vagus, extensive neuron labeling via the stomach or intestine seems unlikely. Laryngeal occlusion did not alter the topographic location or quantity of the neurons labeled by CTB injected through a tracheostomy. Moreover, the pattern of sensory fiber labeling did not coincide with that reported after injections of anterograde neuronal markers into upper gastrointestinal organs. Consistent with the findings of other studies of the sensory innervation of the trachea and lungs (15, 18) , the highest density of labeled sensory terminals was in the commissural subnucleus of the nucleus of the solitary tract below the obex and in the medial and ventrolateral subnuclei above the obex. In contrast, Altschuler et al. (2) reported sensory fiber labeling of the central and gelatinous subnuclei after injections of anterograde tracers into the esophagus and stomach of the rat. Innervation targets of neurons labeled retrogradely by CTB. If we exclude nonselective labeling, we are left with only two plausible explanations for our findings. The first is that CTB labeled a population of medullary vagal motoneurons that provide innervation to the few intrinsic neurons found in the tracheal lamina propria (see Fig. 11 ). The function of these neurons can only be presumed from their location. In animals that, like the dog, have a well-developed system of tracheal glands, intrinsic neurons located in this layer or in the neighboring submucosa can be seen sending nerve fibers to the glandular epithelium (33) . It is therefore reasonable to speculate that the lamina propria and submucosal neurons play a role in the regulation of tracheal secretions. Even if these neurons are indeed the target of the medullary neurons labeled by intraluminal CTB, it is difficult to reconcile their rarity in the trachea (they are absent altogether from the bronchial mucosa) with the abundance of CTB-labeled neuronal somata in the medulla.
This disparity prompts a second explanation, this one based on the idea that some medullary vagal motoneurons may provide direct innervation to epithelial or vascular effector organs in the airway mucosa. Such a proposal is not without precedent in other divisions of the parasympathetic system. Specifically, both degeneration studies after eyeball enucleation and retrograde tracer experiments indicate that the ciliary muscle receives a substantial proportion of its parasympathetic nerves directly from midbrain neurons, bypassing the ciliary ganglion (16, 32) . Although further experimental evidence is needed, a similar arrangement for the vagal innervation of the airways and lungs could also explain the extensive labeling of medullary neurons by CTB, FluoroGold, and even pseudorabies virus injected into the lung parenchyma (12, 27, 28) where ganglion neurons are also rare.
Specificity of vagal innervation: double-labeling experiments. Regardless of the ultimate identity of their innervation targets, many of the individual medullary neurons labeled by intraluminal CTB were also labeled by FluoroGold injections into the tracheal adventitia or the lung parenchyma. This finding, which was highly consistent between rats, denotes a surprising lack of specificity in the distribution of parasympathetic inputs in different tissues within the airway wall.
The FluoroGold injections into the tracheal adventitia were designed to reach the vicinity of the longitudinal nerve and superficial muscular plexi, which contain the majority of the intrinsic neurons of the mammalian trachea (3, 9, 26, 33) . Because of the existence of a natural cleavage plane between the trachea and the esophagus, the small volume of injectate, and the precautions taken to orient the pipette away from the tracheal lumen, we believe that the injected FluoroGold remained separated from the tracheal submucosa or mucosa. The extensive FluoroGold labeling of neuronal somata in the dorsal motor nucleus of the vagus suggests that the spread of these injections included endings from motor fibers innervating the Values are medians; nos. in parentheses, 10th-90th percentiles. CTB was injected into the tracheal lumen; FluoroGold was injected into either the dorsal tracheal adventitia or the apical lobe of the right lung. Double labeled, CTB ϩ FluoroGold. esophagus, an unavoidable consequence of the proximity of this organ to the trachea (and also an additional proof that the injections were located on the dorsal side of the tracheal adventitia).
The FluoroGold injections into the right lung were intended to label what we believed to be a population of vagal motoneurons committed to the innervation of intrapulmonary ganglia. This interpretation needs to be revised, however, in light of the current results. Specifically, the fact that most of the neurons labeled by intraluminal injections of CTB were also labeled by FluoroGold has two potential implications to the contrary. First, there is clearly a subset of neurons labeled by the intraparenchymal injections, the endings of which are within the reach of CTB molecules translocated across the airway epithelium. This is, once again, unlikely to be the case in large bronchi where ganglia reside (24, 31, 33) because in those locations, the bodies of the ganglion neurons are separated from the mucosa and submucosa by a considerable diffusion distance. In addition, the finding that FluoroGold injections into one single lobe reached most of the medullary neurons labeled transepithelially by CTB implies that many of these neurons have multilobar projections and may therefore be involved in the innervation of multiple airway segments.
Summary. Our results demonstrate a novel use of CTB as a transepithelial neuronal marker in the airways. The medullary parasympathetic neurons and fibers identified through this route, however, lack both distinctive topographic characteristics and target specificity. These findings support the notion that it is the role of the diverse populations of airway intrinsic neurons (9, 24) to impart functional selectivity to the parasympathetic outflow carried by the vagus nerves to the airways.
